US2009053334A1PendingUtilityA1

Ghrelin production promoter

Assignee: NAT UNI CORP HOKKAIDO UNIVERSIPriority: Jan 31, 2006Filed: Dec 18, 2006Published: Feb 26, 2009
Est. expiryJan 31, 2026(expired)· nominal 20-yr term from priority
A61P 9/00A61P 5/10A61P 9/10A61P 5/00A61P 25/28A61P 11/00A61K 36/48A61K 36/28A61K 36/23A61K 36/75
46
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The objectives are to find a substance or a composition capable of promoting the production of ghrelin with physiological activities such as growth hormone secretion effect, and to provide a pharmaceutical comprising it as the active ingredient. The pharmaceutical is a ghrelin production promoter comprising Rikkunshi-to as the active ingredient.

Claims

exact text as granted — not AI-modified
1 . A ghrelin production promoter, comprising Rikkunshi-to as the active ingredient. 
   
   
       2 . A growth hormone secretion promoter, comprising Rikkunshi-to as the active ingredient. 
   
   
       3 . A therapeutic agent for myocardial infarction, comprising Rikkunshi-to as the active ingredient. 
   
   
       4 . A therapeutic agent for heart failure, comprising Rikkunshi-to as the active ingredient. 
   
   
       5 . A therapeutic agent for Alzheimer's disease, comprising Rikkunshi-to as the active ingredient. 
   
   
       6 . A therapeutic agent for chronic obstructive pulmonary disease, comprising Rikkunshi-to as the active ingredient.

Join the waitlist — get patent alerts

Track US2009053334A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.